More than 60% of probiotic supplements in the US may lack sufficient information on their labels to allow consumers to make informed decisions, according to a new study led by Dr Dan Merenstein from Georgetown University Medical Center.
Pet owners are more likely to support the legalization of marijuana than the overall population, according to a recent Packaged Facts survey. They’re also more likely to agree that both prescription and OTC hemp, CBD, and cannabis products should be legal.
The US Food and Drug Administration issued a warning on Monday advising pregnant women to avoid the use of dietary supplements containing the ingredient vinpocetine. Industry stakeholders wondered if the missive has more to do with ingredient’s regulatory...
Presentations at the recent FDA meeting on CBD outlined the concerns some academics in the field have about the quality and safety of the products that are on the market.
A joint webinar put on by Global Organization of EPA and DHA Omega 3s (GOED) and the United Natural Products Alliance (UNPA) will help companies understand the intentional adulteration provisions of FSMA.
Friday’s public meeting was an illuminating day of presentations, with multiple viewpoints and interests being aired. On the dietary supplements side, there were strong calls for companies to take the front door with the Agency.
Early returns from the FDA meeting on CBD regulation give a glimpse of the complexity of the regulatory questions, which might stretch the timeline for a new legal framework to extent beyond which many in the industry would find acceptable.
Frustration filled the air at the Dietary Supplements Regulatory Summit earlier this month when it became apparent that no progress has been made in the industry’s push for FDA to drop weight requirements on probiotic product labels.
The main purpose of the Botanical Safety Consortium, a public-private effort bringing together stakeholders in the botanical supplements space, is “advancing the science of botanical safety evaluation, [and is] not involved in regulatory decisions or...
A new force is shaping the dietary supplement market, one that operates largely outside of normal industry channels. The growth of the online sales channel, and brands that operate exclusively in that space, is an increasingly powerful force.
A study published recently has found a level of liver toxicity for CBD, putting up a big caveat to the notion within the hemp/CBD world that its products have nothing in the way of safety concerns.
Neptune Wellness Solutions has moved into the CBD field in the United States in a big way with the acquisition of North Carolina hemp products producer SugarLeaf Labs.
Banned Substances Control Group has published its own list of ingredients that show up in dietary supplements but are of dubious regulatory provenance.
Italy’s National Institute of Health reports a further six new hepatitis incidences linked to the consumption of turmeric-based food supplements bringing the total to ten cases.
